StonvexLoading…
StonvexStonvexStonvexCore line items from AXTA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $1.34B | $1.25B | $5.12B | $3.85B | $2.57B |
Operating Income | Not available | $146.00M | $735.00M | $573.00M | $369.00M |
Net Income | Not available | $90.00M | $378.00M | $318.00M | $208.00M |
EPS (Diluted) | $0.66 | $0.42 | $1.74 | $1.46 | $0.95 |
Total Assets | Not available | $7.56B | $7.60B | $7.76B | $7.78B |
Total Liabilities | Not available | $5.09B | $5.21B | $5.43B | $5.47B |
Cash & Equivalents | Not available | $608.00M | $657.00M | $606.00M | $625.00M |
Free Cash Flow OCF − CapEx | Not available | $18.00M | $453.00M | $167.00M | $80.00M |
Shares Outstanding | Not available | 214.60M | 217.00M | 217.90M | 218.90M |